We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO Suggests Regulatory Changes for Drugs, Biologics at FDA
BIO Suggests Regulatory Changes for Drugs, Biologics at FDA
July 8, 2011
The Biotechnology Industry Organization (BIO) has unveiled what it calls a progressive approach to FDA drug and biologic approvals in which a product is approved for a narrow population then gradually expanded over time as its efficacy and safety are shown in additional clinical trials.